Global Aortic Aneurysm Market
Global Aortic Aneurysm Market

Aortic Aneurysm Comprehensive Study by Type (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA)), Treatment (Endovascular Aneurysm Repair, Open Surgical Repair), End Use (Ambulatory Surgical Centers, Hospital), Product (Stent Graft, Catheter)

Aortic Aneurysm Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Nov 2020 Edition 204 Pages 215 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Aortic Aneurysm Market Scope
An aortic aneurysm is an abnormal bulge that occurs in the wall of the major blood vessel (aorta) that carries blood from the heart to the body. Aortic aneurysms can occur anywhere in the aorta and may be tube-shaped (fusiform) or round (saccular). An aortic dissection occurs when a tear develops in the inner layer of the wall of the aorta. This causes one or more of the layers of the wall of the aorta to separate, which weakens the wall of the aorta. Having an aortic aneurysm also increases your risk that the aneurysm can burst (rupture). Aortic Aneurysm is expected to increase in forthcoming years, due to the increase in the geriatric population and the rise in tobacco consumption.

The Aortic Aneurysm market study is segmented by Type (Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA)) and major geographies with country level break-up.

In this market, companies are completely focused on research and development to develop drugs or devices. The companies are exploring the market in new regions by expansions, investments, collaboration, and partnership as their preferred strategies Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Aortic Aneurysm market throughout the predicted period.

Medtronic Plc (Ireland), Cook Medical (United States), Terumo Medical Corporation (United States), Microport Scientific Corporation (China), Getinge (Sweden), Endologix, Inc. (United States), W. L. Gore & Associates (United States), Lombard Medical Limited (United Kingdom), CryoLife, Inc. (United States) and Cardinal Health, Inc (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Aortic Aneurysm market by Type, Application and Region.

On the basis of geography, the market of Aortic Aneurysm has been segmented into .

Market Leaders and their expansionary development strategies
In April 2018, Vascutek Ltd and Bolton Medical, Inc. have merged to produce one single business unit. It is expected that following this acquisition, the merged company is likely to reinforce its position in the global market and expand its portfolio of medical products.
In May 2020, Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted approval of the TREO™ Abdominal Aortic Stent-Graft System for sale in the United States for the treatment of patients with abdominal aortic aneurysms (AAA).


Market Trend
  • Introduction of New Diagnosis Tools

Market Drivers
  • High Prevalence of Tobacco Smoking in the Developed and Developing Region
  • Rise in the Geriatric Population with Cardiovascular Diseases

Opportunities
  • Reimbursement Scenarios for the Surgical Treatment of Aortic Aneurysms
  • Continuous Advancements, in terms of Technology, in Endovascular Surgical Procedures

Restraints
  • High Treatment Cost and Cost of Device

Challenges
  • Less Treatment Options Available for Thoracic Aortic Aneurysm Repair
  • Biochemical Issues in the Endovascular Device Design


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Aortic Aneurysm Manufacturers, Suppliers, and Dealers, Medical Devices Companies, Raw Material Suppliers, Market Research and Consulting Service Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and Hospitals and Healthcare Institutions

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic Aneurysm (TAA)
By Treatment
  • Endovascular Aneurysm Repair
  • Open Surgical Repair

By End Use
  • Ambulatory Surgical Centers
  • Hospital

By Product
  • Stent Graft
  • Catheter

By Regions
    • 1. Market Overview
      • 1.1. Introduction
      • 1.2. Scope/Objective of the Study
        • 1.2.1. Research Objective
    • 2. Executive Summary
      • 2.1. Introduction
    • 3. Market Dynamics
      • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. High Prevalence of Tobacco Smoking in the Developed and Developing Region
        • 3.2.2. Rise in the Geriatric Population with Cardiovascular Diseases
      • 3.3. Market Challenges
        • 3.3.1. Less Treatment Options Available for Thoracic Aortic Aneurysm Repair
        • 3.3.2. Biochemical Issues in the Endovascular Device Design
      • 3.4. Market Trends
        • 3.4.1. Introduction of New Diagnosis Tools
    • 4. Market Factor Analysis
      • 4.1. Porters Five Forces
      • 4.2. Supply/Value Chain
      • 4.3. PESTEL analysis
      • 4.4. Market Entropy
      • 4.5. Patent/Trademark Analysis
    • 5. Global Aortic Aneurysm, by Type, Treatment, End Use and Product (value) (2014-2019)
      • 5.1. Introduction
      • 5.2. Global Aortic Aneurysm (Value)
        • 5.2.1. Global Aortic Aneurysm by: Type (Value)
          • 5.2.1.1. Abdominal Aortic Aneurysm (AAA)
          • 5.2.1.2. Thoracic Aortic Aneurysm (TAA)
        • 5.2.2. Global Aortic Aneurysm by: Treatment (Value)
          • 5.2.2.1. Endovascular Aneurysm Repair
          • 5.2.2.2. Open Surgical Repair
        • 5.2.3. Global Aortic Aneurysm by: End Use (Value)
          • 5.2.3.1. Ambulatory Surgical Centers
          • 5.2.3.2. Hospital
        • 5.2.4. Global Aortic Aneurysm by: Product (Value)
          • 5.2.4.1. Stent Graft
          • 5.2.4.2. Catheter
    • 6. Aortic Aneurysm: Manufacturers/Players Analysis
      • 6.1. Competitive Landscape
        • 6.1.1. Market Share Analysis
          • 6.1.1.1. Top 3
          • 6.1.1.2. Top 5
      • 6.2. Peer Group Analysis (2019)
      • 6.3. BCG Matrix
      • 6.4. Company Profile
        • 6.4.1. Medtronic Plc (Ireland)
          • 6.4.1.1. Business Overview
          • 6.4.1.2. Products/Services Offerings
          • 6.4.1.3. Financial Analysis
          • 6.4.1.4. SWOT Analysis
        • 6.4.2. Cook Medical (United States)
          • 6.4.2.1. Business Overview
          • 6.4.2.2. Products/Services Offerings
          • 6.4.2.3. Financial Analysis
          • 6.4.2.4. SWOT Analysis
        • 6.4.3. Terumo Medical Corporation (United States)
          • 6.4.3.1. Business Overview
          • 6.4.3.2. Products/Services Offerings
          • 6.4.3.3. Financial Analysis
          • 6.4.3.4. SWOT Analysis
        • 6.4.4. Microport Scientific Corporation (China)
          • 6.4.4.1. Business Overview
          • 6.4.4.2. Products/Services Offerings
          • 6.4.4.3. Financial Analysis
          • 6.4.4.4. SWOT Analysis
        • 6.4.5. Getinge (Sweden)
          • 6.4.5.1. Business Overview
          • 6.4.5.2. Products/Services Offerings
          • 6.4.5.3. Financial Analysis
          • 6.4.5.4. SWOT Analysis
        • 6.4.6. Endologix, Inc. (United States)
          • 6.4.6.1. Business Overview
          • 6.4.6.2. Products/Services Offerings
          • 6.4.6.3. Financial Analysis
          • 6.4.6.4. SWOT Analysis
        • 6.4.7. W. L. Gore & Associates (United States)
          • 6.4.7.1. Business Overview
          • 6.4.7.2. Products/Services Offerings
          • 6.4.7.3. Financial Analysis
          • 6.4.7.4. SWOT Analysis
        • 6.4.8. Lombard Medical Limited (United Kingdom)
          • 6.4.8.1. Business Overview
          • 6.4.8.2. Products/Services Offerings
          • 6.4.8.3. Financial Analysis
          • 6.4.8.4. SWOT Analysis
        • 6.4.9. CryoLife, Inc. (United States)
          • 6.4.9.1. Business Overview
          • 6.4.9.2. Products/Services Offerings
          • 6.4.9.3. Financial Analysis
          • 6.4.9.4. SWOT Analysis
        • 6.4.10. Cardinal Health, Inc (United States)
          • 6.4.10.1. Business Overview
          • 6.4.10.2. Products/Services Offerings
          • 6.4.10.3. Financial Analysis
          • 6.4.10.4. SWOT Analysis
    • 7. Global Aortic Aneurysm Sale, by Type, Treatment, End Use and Product (value) (2020-2025)
      • 7.1. Introduction
      • 7.2. Global Aortic Aneurysm (Value)
        • 7.2.1. Global Aortic Aneurysm by: Type (Value)
          • 7.2.1.1. Abdominal Aortic Aneurysm (AAA)
          • 7.2.1.2. Thoracic Aortic Aneurysm (TAA)
        • 7.2.2. Global Aortic Aneurysm by: Treatment (Value)
          • 7.2.2.1. Endovascular Aneurysm Repair
          • 7.2.2.2. Open Surgical Repair
        • 7.2.3. Global Aortic Aneurysm by: End Use (Value)
          • 7.2.3.1. Ambulatory Surgical Centers
          • 7.2.3.2. Hospital
        • 7.2.4. Global Aortic Aneurysm by: Product (Value)
          • 7.2.4.1. Stent Graft
          • 7.2.4.2. Catheter
    • 8. Appendix
      • 8.1. Acronyms
    • 9. Methodology and Data Source
      • 9.1. Methodology/Research Approach
        • 9.1.1. Research Programs/Design
        • 9.1.2. Market Size Estimation
        • 9.1.3. Market Breakdown and Data Triangulation
      • 9.2. Data Source
        • 9.2.1. Secondary Sources
        • 9.2.2. Primary Sources
      • 9.3. Disclaimer
    List of Tables
    • Table 1. Aortic Aneurysm: by Type(USD Million)
    • Table 2. Aortic Aneurysm: by Treatment(USD Million)
    • Table 3. Aortic Aneurysm: by End Use(USD Million)
    • Table 4. Aortic Aneurysm: by Product(USD Million)
    • Table 5. Company Basic Information, Sales Area and Its Competitors
    • Table 6. Company Basic Information, Sales Area and Its Competitors
    • Table 7. Company Basic Information, Sales Area and Its Competitors
    • Table 8. Company Basic Information, Sales Area and Its Competitors
    • Table 9. Company Basic Information, Sales Area and Its Competitors
    • Table 10. Company Basic Information, Sales Area and Its Competitors
    • Table 11. Company Basic Information, Sales Area and Its Competitors
    • Table 12. Company Basic Information, Sales Area and Its Competitors
    • Table 13. Company Basic Information, Sales Area and Its Competitors
    • Table 14. Company Basic Information, Sales Area and Its Competitors
    • Table 15. Aortic Aneurysm: by Type(USD Million)
    • Table 16. Aortic Aneurysm: by Treatment(USD Million)
    • Table 17. Aortic Aneurysm: by End Use(USD Million)
    • Table 18. Aortic Aneurysm: by Product(USD Million)
    • Table 19. Research Programs/Design for This Report
    • Table 20. Key Data Information from Secondary Sources
    • Table 21. Key Data Information from Primary Sources
    List of Figures
    • Figure 1. Porters Five Forces
    • Figure 2. Supply/Value Chain
    • Figure 3. PESTEL analysis
    • Figure 4. Global Aortic Aneurysm: by Type USD Million (2014-2019)
    • Figure 5. Global Aortic Aneurysm: by Treatment USD Million (2014-2019)
    • Figure 6. Global Aortic Aneurysm: by End Use USD Million (2014-2019)
    • Figure 7. Global Aortic Aneurysm: by Product USD Million (2014-2019)
    • Figure 8. Global Aortic Aneurysm share by Players 2019 (%)
    • Figure 9. Global Aortic Aneurysm share by Players (Top 3) 2019(%)
    • Figure 10. Global Aortic Aneurysm share by Players (Top 5) 2019(%)
    • Figure 11. BCG Matrix for key Companies
    • Figure 12. Medtronic Plc (Ireland) Revenue, Net Income and Gross profit
    • Figure 13. Medtronic Plc (Ireland) Revenue: by Geography 2019
    • Figure 14. Cook Medical (United States) Revenue, Net Income and Gross profit
    • Figure 15. Cook Medical (United States) Revenue: by Geography 2019
    • Figure 16. Terumo Medical Corporation (United States) Revenue, Net Income and Gross profit
    • Figure 17. Terumo Medical Corporation (United States) Revenue: by Geography 2019
    • Figure 18. Microport Scientific Corporation (China) Revenue, Net Income and Gross profit
    • Figure 19. Microport Scientific Corporation (China) Revenue: by Geography 2019
    • Figure 20. Getinge (Sweden) Revenue, Net Income and Gross profit
    • Figure 21. Getinge (Sweden) Revenue: by Geography 2019
    • Figure 22. Endologix, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 23. Endologix, Inc. (United States) Revenue: by Geography 2019
    • Figure 24. W. L. Gore & Associates (United States) Revenue, Net Income and Gross profit
    • Figure 25. W. L. Gore & Associates (United States) Revenue: by Geography 2019
    • Figure 26. Lombard Medical Limited (United Kingdom) Revenue, Net Income and Gross profit
    • Figure 27. Lombard Medical Limited (United Kingdom) Revenue: by Geography 2019
    • Figure 28. CryoLife, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 29. CryoLife, Inc. (United States) Revenue: by Geography 2019
    • Figure 30. Cardinal Health, Inc (United States) Revenue, Net Income and Gross profit
    • Figure 31. Cardinal Health, Inc (United States) Revenue: by Geography 2019
    • Figure 32. Global Aortic Aneurysm: by Type USD Million (2020-2025)
    • Figure 33. Global Aortic Aneurysm: by Treatment USD Million (2020-2025)
    • Figure 34. Global Aortic Aneurysm: by End Use USD Million (2020-2025)
    • Figure 35. Global Aortic Aneurysm: by Product USD Million (2020-2025)
    Some of the key companies/manufacturers profiled in the report
    • Medtronic Plc (Ireland)
    • Cook Medical (United States)
    • Terumo Medical Corporation (United States)
    • Microport Scientific Corporation (China)
    • Getinge (Sweden)
    • Endologix, Inc. (United States)
    • W. L. Gore & Associates (United States)
    • Lombard Medical Limited (United Kingdom)
    • CryoLife, Inc. (United States)
    • Cardinal Health, Inc (United States)
    Select License Type
    Sample Report Enquiry Before Buy Request Discount

    Speak with Analyst

    Want to find out more about this report?

    Get Free Consultation